Connecticut-based Hartford HealthCare has collaborated with Memorial Sloan Kettering Cancer Center in New York to open a new cancer center in Fairfield, Connecticut, that's being called the first of its kind in the area.
The 25,000-square-foot facility boasts upgraded technology as well as personalized care plans and a focus on research initiatives.
The Fairfield Cancer Center will offer the first Varian Ethos Radiation Therapy System in the state. The advanced radiation therapy system uses adaptive intelligence to personalize treatments in real time and to customize treatment to each person's unique anatomy.
The health system also touted its team of specialized experts, as well as a serene environment designed to reduce stress and promote recovery.
"It's about bringing hope to our patients by giving them direct access to the best cancer care in the world," said Jeffrey A. Flaks, president and CEO of Hartford HealthCare. "This new cancer center epitomizes our relentless pursuit of excellence to provide world-class cancer care for every patient."
WHAT'S THE IMPACT
Treatments offered at the new center include medical oncology, infusion, pain management, palliative care, pharmacy and laboratory services, clinical trials, surgical oncology, integrative medicine, and radiology and support services.
Fairfield Cancer Center is a care partner of Memorial Sloan Kettering Cancer Center (MSK), which means that Hartford HealthCare physicians at this location will have access to MSK's expertise, the system said. Some physicians also will observe MSK physicians performing new techniques.
"We're excited to continue our collaboration with MSK's world-renowned experts to elevate cancer care for patients in Connecticut," said Flaks.
THE LARGER TREND
Healthcare organizations that become MSK Care Partners collaborate with MSK to ensure patients in community settings receive specialized cancer care.
The partnerships facilitate the integration of MSK Standards of Care into local oncology practices through knowledge-sharing, expanded access to clinical trials, enhanced educational opportunities and collaboration with cancer experts. According to Hartford HealthCare, these organizations undergo regular quality reviews to adopt the latest and most effective cancer care approaches grounded in scientific evidence.
Jeff Lagasse is editor of Healthcare Finance News.
Email: jlagasse@himss.org
Healthcare Finance News is a HIMSS Media publication.